MX9207559A - Revestimientos de prolamina para medicamentos administrables oralmente que enmascaran el sabor. - Google Patents

Revestimientos de prolamina para medicamentos administrables oralmente que enmascaran el sabor.

Info

Publication number
MX9207559A
MX9207559A MX9207559A MX9207559A MX9207559A MX 9207559 A MX9207559 A MX 9207559A MX 9207559 A MX9207559 A MX 9207559A MX 9207559 A MX9207559 A MX 9207559A MX 9207559 A MX9207559 A MX 9207559A
Authority
MX
Mexico
Prior art keywords
taste
mask
orally administrable
prolamine
coatings
Prior art date
Application number
MX9207559A
Other languages
English (en)
Inventor
Glenn A Meyer
Terrence B Mazer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9207559A publication Critical patent/MX9207559A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a fracciones de prolamina, de proteínas de granos, que se aplican en una proporción de 5 a 100, en relación al agente activo que se esta revistiendo, para prevenir efectivamente la división de las drogas insolubles en agua y de las solubles en agua, a pH neutrales en la boca y por lo tanto enmascarar el sabor de las drogas administradas oralmente, las cuales normalmente tienen un sabor amargo, sin sacrificar la biodisponibilidad.
MX9207559A 1991-12-31 1992-12-24 Revestimientos de prolamina para medicamentos administrables oralmente que enmascaran el sabor. MX9207559A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81545891A 1991-12-31 1991-12-31

Publications (1)

Publication Number Publication Date
MX9207559A true MX9207559A (es) 1994-05-31

Family

ID=25217849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207559A MX9207559A (es) 1991-12-31 1992-12-24 Revestimientos de prolamina para medicamentos administrables oralmente que enmascaran el sabor.

Country Status (7)

Country Link
EP (1) EP0620730B1 (es)
AU (1) AU661753B2 (es)
CA (1) CA2126200C (es)
DE (1) DE69231472T2 (es)
IL (1) IL104093A (es)
MX (1) MX9207559A (es)
WO (1) WO1993012771A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (es) * 1992-07-30 1996-03-01 Pfizer
JPH10108630A (ja) * 1996-10-04 1998-04-28 Showa Sangyo Co Ltd コーティング時の作業性が良い食品用艶出しコーティング剤
DE69708321D1 (de) * 1996-12-18 2001-12-20 Isocell Neuilly Sur Seine Biodegradierbare prolaminkapsel
EP1024788A1 (en) 1997-10-03 2000-08-09 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
WO2018056123A1 (ja) * 2016-09-26 2018-03-29 株式会社山田養蜂場本社 安定で呈味の改善された酵素分解ローヤルゼリー顆粒
CN115462493B (zh) * 2022-09-27 2023-09-05 青岛啤酒股份有限公司 基于植物多肽封装掩味的复合纳米颗粒及所得饮品

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR760403A (fr) * 1932-11-22 1934-02-22 Dispositif d'arrêt du déroulement des bandes tendues
FR1323056A (fr) * 1961-03-20 1963-04-05 Marion Laboratories Inc Procédé et composition pour l'enrobage des comprimés pharmaceutiques
NL282963A (es) * 1962-10-29
FR1447175A (fr) * 1964-12-30 1966-07-29 Oreal Nouveau produit pour effectuer la coloration de cheveux décolorés
US3497369A (en) * 1968-07-17 1970-02-24 Corn Products Co Zein-containing plastic composition
US3802896A (en) * 1972-05-15 1974-04-09 Nutrilite Products Color concentrated base dispersion used in tablet film coating
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
BR8506634A (pt) * 1984-12-20 1986-09-09 Rhone Poulenc Sante Composicoes para o revestimento de aditivos alimentares destinados aos ruminantes e granulados sob forma de microcapsulas assim revestidos
WO1991006227A1 (en) * 1989-11-06 1991-05-16 Opta Food Ingredients, Inc. Protein-based edible coatings

Also Published As

Publication number Publication date
AU3415993A (en) 1993-07-28
CA2126200C (en) 1998-10-20
IL104093A0 (en) 1993-05-13
EP0620730A4 (en) 1995-05-17
DE69231472T2 (de) 2001-05-10
EP0620730B1 (en) 2000-09-20
DE69231472D1 (de) 2000-10-26
WO1993012771A1 (en) 1993-07-08
IL104093A (en) 1999-06-20
EP0620730A1 (en) 1994-10-26
AU661753B2 (en) 1995-08-03
CA2126200A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
ES2156028T3 (es) Composiciones que contienen tetrahidrolipstatina
HUP0101427A2 (hu) Pezsgő készítmények
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
WO1997048391A3 (en) Methods and compositions comprising r-ibuprofen
MX9207559A (es) Revestimientos de prolamina para medicamentos administrables oralmente que enmascaran el sabor.
HUE031034T2 (en) A method of preventing and treating mucosal inflammation
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
BR0204767A (pt) Composição farmacêutica
ITMI921831A1 (it) Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
DE69919533D1 (de) Proteinhaltige arzneimittel
DK342989D0 (da) Betaendelseshaemmende middel
MX9200728A (es) Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.
WO2000000214A3 (en) Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
WO2000072823A8 (en) Preparations for the application of anti-inflammatory agents
NZ334836A (en) Liquid alendronate formulations and their use in preventing bone resorption
CA2420640A1 (en) Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
CA2429793A1 (en) Interferon therapeutic effect enhancer
GEP20043377B (en) Pharmaceutical Complex
DE69626401D1 (de) Arzneimittel zur topischen anwendung
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
US20040023937A1 (en) Anti-cancer formulation
CA2157590A1 (en) Use of terbinafine for the therapeutic treatment of pneumocystosis
Vazquez New vitamin B-12 gel, instead of injection
WO1996016652A3 (en) Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections